Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Levofloxacin-Loaded Nanoparticles Decrease Emergence of Fluoroquinolone Resistance in Escherichia coli.

Microbial drug resistance (Larchmont, N.Y.) - 1 Oct 2018

Hadiya Safy, Liu Xiaoqiang, Abd El-Hammed Wegdan, Elsabahy Mahmoud, Aly Sherine A

Abstract excerpt

Antimicrobial resistance is a major global health problem that is developed upon exposure of bacteria to antimicrobial agents, and, thus, reducing or eliminating the ability of the currently available antibacterial drugs to eradicate bacterial infections. The aim of the current study was to encapsulate levofloxacin (third generation fluoroquinolones) into chitosan (CS) nanoparticles, to evaluate the antibacterial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to DNA Gyrase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Escherichia coli

Share to Fluoroquinolones

Share to Levofloxacin

Share to Microbial Sensitivity Tests

Share to Nanoparticles

Source

Identifiers

PMID: 29431570
DOI: 10.1089/mdr.2017.0304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Levofloxacin-Loaded Nanoparticles Decrease Emergence of Fluoroquinolone Resistance in Escherichia coli.PMID 29431570Read ↗

Profile of gyrA gene mutation in clinical isolate of levofloxacin resistant Escherichia coli.Semantic proximity Read ↗

Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.Semantic proximity Read ↗

Molecular characterization and differential effects of levofloxacin and ciprofloxacin on the potential for developing quinolone resistance among clinical Pseudomonas aeruginosa isolatesSemantic proximity Read ↗

Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli.Semantic proximity Read ↗

Emergence of resistance to ciprofloxacin in Neisseria meningitidis in Brazil.Semantic proximity Read ↗

Observation of a New Pattern of Mutations in gyrA and parC within Escherichia coli Exhibiting Fluroquinolone ResistanceSemantic proximity Read ↗

Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.Semantic proximity Read ↗

Ciprofloxacin- and levofloxacin-loaded nanoparticles efficiently suppressed fluoroquinolone resistance and biofilm formation in Acinetobacter baumanniiSemantic proximity Read ↗

Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli.Semantic proximity Read ↗

Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.Semantic proximity Read ↗

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosaSemantic proximity Read ↗

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.